BrightSpring Health Services, Inc. (BTSG)
- Previous Close
23.49 - Open
23.46 - Bid 17.08 x 200
- Ask 29.70 x 200
- Day's Range
22.97 - 23.85 - 52 Week Range
10.15 - 24.82 - Volume
701,817 - Avg. Volume
1,883,919 - Market Cap (intraday)
4.147B - Beta (5Y Monthly) --
- PE Ratio (TTM)
88.15 - EPS (TTM)
0.27 - Earnings Date Jul 31, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
26.32
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. It operates through two segments, Pharmacy Solutions and Provider Services. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
www.brightspringhealth.com37,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BTSG
View MorePerformance Overview: BTSG
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BTSG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BTSG
View MoreValuation Measures
Market Cap
4.09B
Enterprise Value
6.76B
Trailing P/E
87.00
Forward P/E
40.49
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.40
Price/Book (mrq)
2.43
Enterprise Value/Revenue
0.57
Enterprise Value/EBITDA
14.37
Financial Highlights
Profitability and Income Statement
Profit Margin
0.48%
Return on Assets (ttm)
4.39%
Return on Equity (ttm)
2.74%
Revenue (ttm)
11.86B
Net Income Avi to Common (ttm)
47.08M
Diluted EPS (ttm)
0.27
Balance Sheet and Cash Flow
Total Cash (mrq)
59.48M
Total Debt/Equity (mrq)
160.76%
Levered Free Cash Flow (ttm)
-385.76M